01 · Determine
Understand where the signal is changing.
Primary hypogonadism
The testicles do not respond adequately despite appropriate signaling from the brain. Causes can include injury, infection, genetic conditions, treatment effects, and age-related changes.
Secondary hypogonadism
The hypothalamus or pituitary does not provide an adequate signal to stimulate testosterone production. Medication effects, pituitary conditions, systemic illness, and other factors may contribute.
Mixed or functional patterns
Some men have features of both. Health and lifestyle factors may also influence total testosterone, free testosterone, SHBG, symptoms, and recovery.
02 · Decide
Review every appropriate treatment path.
A treatment plan may involve correcting a contributing condition, adjusting medications or lifestyle factors, supporting natural testosterone production, or using testosterone replacement.
The choice depends on the confirmed diagnosis, symptoms, other health conditions, personal preferences, cost, and fertility goals. Testosterone therapy is generally avoided when near-term fertility is a priority unless a specialist recommends a different strategy.
03 · Refine
Adjust without guessing.
Evaluate response
Review whether target symptoms are improving and whether any new or unwanted effects have appeared.
Monitor safety
Monitor testosterone levels, blood counts, blood pressure, prostate risk when appropriate, and other patient-specific markers.
Revisit the plan
Change the dose, frequency, formulation, or treatment path when the evidence and patient experience support it.
Common process questions
What testosterone formulations are offered?
Veritas primarily works with injectable testosterone and compounded topical cream. Each has different convenience, absorption, transfer, and monitoring considerations.
Do you offer pellets?
Veritas does not currently offer pellet therapy. The clinic favors treatments that allow the dose to be adjusted more readily as symptoms and lab markers change.
How often is blood work needed?
Frequency depends on the treatment, stability of the dose, response, age, and individual risk factors. Testing is typically more frequent early in therapy and becomes less frequent after the plan is stable.
Do you routinely use estrogen blockers?
No. Estrogen has important functions in men. Aromatase inhibitors are considered only when an individual evaluation supports their use, rather than being added automatically to every protocol.